Swiftmerge Acquisition Corp. (IVCP)
| Previous close | 10.77 |
| Open | 10.77 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 10.79 - 10.79 |
| 52-week range | 10.00 - 12.20 |
| Volume | |
| Avg. volume | 16,998 |
| Market cap | 73.803M |
| Beta (5Y monthly) | 0.01 |
| PE ratio (TTM) | 49.05 |
| EPS (TTM) | 0.22 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Insider MonkeyFarallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks
In this article, we discuss Farallon Capital: a global and diversified hedge fund and its top stock picks. If you want to skip our detailed analysis of these stocks, go directly to the Top 5 Stock Picks of Farallon Capital. Risk arbitrage or merger arbitrage is one of the most popular strategies that hedge funds […]
Business WireHDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.
NEW YORK & VERO BEACH, Fla., August 11, 2023--HDL Therapeutics, Inc. ("HDL Therapeutics"), a privately held commercial stage biotech company with an FDA-approved cardiovascular therapy the Plasma Delipidation System (PDS-2™ System) for reducing coronary atheroma in patients with homozygous familial hypercholesterolemia (HoFH), has signed a definitive merger agreement with Swiftmerge Acquisition Corp. (NASDAQ: IVCP) ("Swiftmerge"), a special purpose acquisition company with a disruptive consumer
